Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 6/20 | 0.67 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.53 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.53 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | TERT | O14746 | 2/20 | 0.51 |
| ▸ | DTYMK | P23919 | 4/20 | 0.48 |
| ▸ | TYMS | P04818 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13326117 | 1.00 | F2 (0.67) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL21504636 | 0.96 | F2 (0.64) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL26189524 | 0.96 | F2 (0.64) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL26189527 | 0.96 | F2 (0.64) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL21489387 | 0.96 | F2 (0.64) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL29552315 | 0.94 | F2 (0.67) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL30055250 | 0.94 | F2 (0.67) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL31103632 | 0.94 | F2 (0.67) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL29551345 | 0.94 | F2 (0.67) | F2P2RY2P2RY4P2RY6POLB | |
| SCHEMBL30478053 | 0.94 | F2 (0.67) | F2P2RY2P2RY4P2RY6POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070270359-A1 | Nucleic Acid-Based Compounds and Methods of Use Thereof | IYER RADHAKRISHNAN P | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270359-A1 | Nucleic Acid-Based Compounds and Methods of Use Thereof | NT5C3B, HAVCR2, NSUN2 | F2 4405/4885P2RY2 1506/4885P2RY4 1039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.